We aimed to study the effects of LY294002, an inhibitor of class I phosphatidylinositol 3-kinase (PI3K), on proliferation, apoptosis, and autophagy in gastric cancer cell line SGC7901.
The class I phosphatidylinositol 3-kinase (PI3K) pathway plays a central role in the regulation of cell proliferation, growth, differentiation, and survival [1, 2] . Dysregulation of this pathway is frequently observed in a variety of tumors, including brain tumors, breast, ovarian, and other carcinomas [3 5] . Therefore, inhibition of PI3K signaling is being investigated as a potential therapy for cancer.
In mammalian cells, there are three classes of PI3Ks, class I, class II, and class III. Class I and class III PI3K regulate autophagy differently. The class I PI3K/serinethreonine protein kinase (AKT)/mammalian target of rapamycin (mTOR) signal, which is activated in cancer cells through the growth factor receptor, inhibits autophagy [6] . Contradictorily, class III PI3K promotes the sequestration of cytoplasmic material that occurs during autophagy. Class II PI3K activity is thought to have no relevance to the autophagy control [7] . Autophagy has been shown to prolong cell survival under physiologic, pathologic, and pharmacologic stress conditions [8, 9] . Deregulation of autophagy is associated with liver diseases, neurodegenerative diseases, cardiomyopathies, and cancers [8, 10] . Furthermore, like apoptosis, autophagy is found to be suppressed in malignant tumors and in tumorigenesis. Several molecular and cell signaling pathways have been implicated in regulating autophagy, such as Beclin1, death-associated protein kinase, death-associated related protein kinase 1, mitogen-activated kinase, and PI3K/AKT/mTOR pathways [11 13] .
Recent studies have shown that the inhibition of class I PI3K/AKT and its downstream target mTOR contributes to the initiation of autophagy [14, 15] . Therefore, the inhibitor of class I PI3K/AKT/mTOR signaling has emerged as an important and attractive therapeutic target for cancer therapy. However, detailed mechanisms of the relation between apoptosis, autophagy, and necrosis in programmed cell death (PCD) are poorly understood.
according to the manufacturer's suggestions. The final solution used in the experiments was 50 M. This concentration of LY294002 was selected on the basis of our experiments on SGC7901 cells.
Cell culture
SGC7901 gastric cancer cells (Shanghai Institute of Cell Biology, Shanghai, China) were maintained in RPMI 1640 medium (Gibco BRL, Rockville, USA) containing 10% heat-inactivated fetal bovine serum (FBS; Hangzhou Sijiqing Biological Engineering Material Company Limited, Hangzhou, China), 0.03% L-glutamine (Sigma, St. Louis, USA) and incubated in a 5% CO 2 atmosphere at 37 ºC. Cells in mid-log phase were used in experiments.
Cell viability assay
Cell viability was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; Sigma) assay. To determine the time-course of the effects of LY294002 on SGC7901 cells, cells were plated into 96-well microplates (7 10 3 cells/well) and cultured for 24, 48, and or 72 h. Then LY294002 (12.5 M, 25 M, or 50 M) was added to the culture medium and cell viability was assessed with MTT at 24, 48, and 72 h after drug treatment. Later, MTT solution was added to the culture medium (500 g/ml of final concentration) 4 h before the end of treatment and the reaction was stopped by addition of 100 l of 10% acidic sodium dodecyl sulfate. The absorbance value (A) at 570 nm was read using an automatic multiwell spectrophotometer (Bio-Rad, Richmond, USA). The percentage of cell death was calculated as following equation:
Cell death rate=(1 A experiment group /A positive control ) 100% Hoechst 33258 staining After treatment, cell cultures were washed twice with phosphate-buffered saline (PBS) and incubated with 2 M Hoechst 33258 (Beyotime, Nantong, China) for 1 h in the dark at 37 ºC. After washing three times with PBS, the cells were viewed with a fluorescence microscope (Nikon, Tokyo, Japan) equipped with an ultraviolet filter. The images were recorded on a computer with a digital camera (DXM 1200; Nikon) attached to the microscope, and the images were processed by computer. The Hoechst reagent was taken up by the nuclei of the cells, and apoptotic cells showed a bright blue fluorescence.
Visualization of monodansylcadaverine (MDC)-labeled vacuoles
Exponentially growing cells were plated on 24-chamber culture slides, cultured for 24 h, then incubated with LY294002 in RPMI 1640 medium containing 10% FBS for 6 h, 12 h, or 24 h. Autophagic vacuoles were labeled with MDC [16] (Sigma) by incubating cells with 1 M MDC in RPMI 1640 at 37 ºC for 10 min. After incubation, cells were washed three times with PBS and immediately analyzed with a fluorescence microscope (Eclipse TE 300; Nikon) equipped with a filter system (V-2A; excitation filter, 380 420 nm; barrier filter, 450 nm). Images were captured with a CCD camera and imported into Photoshop CS2 (Adobe, San Jose, USA).
Detection and quantification of acidic vesicular organelles with acridine orange (AO)
Vital staining of cells with AO (KeyGEN, Nanjing, China) was carried out essentially as described previously [17] . Exponentially growing cells were plated on 24-chamber culture slides, cultured for 24 h, then incubated with LY294002 in RPMI 1640 containing 10% FBS for 6, 12, or 24 h. AO was added for 15 min at a final concentration of 1 g/ml, and the cells were then washed three times with PBS. Unfixed cells were examined immediately by fluorescence microscopy using a Nikon Eclipse 300 microscope with the red filter set (G-2E/C; excitation 528 553 nm, emission 600 660 nm). Red fluorescence was observed with excitation and emission wavelengths set at 488 nm and 655 nm, respectively. Images were captured with a CCD camera and imported into Photoshop.
Immunofluorescence staining SGC7901 cells were seeded onto 24-chamber culture slides and treated with LY294002 (50 M). After fixation (methanol) for 10 min and blockage (1% bovine serum albumin solved in 0.1% Triton X-100) for 1 h, cells were incubated with rabbit monoclonal primary antibody against active caspase-3, mouse monoclonal primary antibody against p53, or rabbit monoclonal primary antibody against p53-up-regulated modulator of apoptosis (PUMA) (Cell Signaling Technology) diluted 1:200 with PBS containing 1% bovine serum albumin at 4 ºC overnight. Cells were then incubated for 1 h with 1:500 CY3-conjugated sheep anti-rabbit secondary antibody (Sigma) or FITC-conjugated rabbit anti-mouse secondary antibody (Sigma) to visualize the binding sites of the primary antibody under laser confocal microscopy (Leica, Bensheim, Germany).
Real-time quantitative RT-PCR analysis of microtubule-associated protein 1 light chain 3 (LC3)
Total RNA was extracted with the RNAiso reagent kit (TaKaRa, Dalian, China). First-strand cDNA was generated by RT of 2 g total RNA using random primers and Primescript™ RT reagent kit (TaKaRa), according to the manufacturer's instructions, in a total reaction volume of 20 l. The sequences of forward and reverse oligonucleotide primers, specific to the chosen candidate and housekeeping genes, were designed using Primer5 software (http://frodo.wi.mit.edu/cgi-bin/primer5/primer5_www. cgi). The primers for LC3 were 5 -CTTGGATTGGTG-GGATGTTC-3 (forward) and 5 -GATGATGGACTG-TAGGAGCGTGT-3 (reverse), GenBank accession No. NM_018370, nucleotides, 758 870. The primers foractin were 5 -ATTGCCGACAGGATGCAGA-3 (forward) and 5 -GAGTACTTGCGCTCAGGAGGA-3 (reverse), GenBank accession No. NM_001101, nucleotides, 998 1086. Real-time quantitative PCR was also carried out in an iCycler 5 iQ real-time PCR system (Bio-Rad). An 80-fold dilution of each cDNA was amplified in a 20 l volume, using the SYBR Premix EX Taq kit (TaKaRa), with 500 nM final concentrations of each primer. The amplification specificity was checked by melting curve analysis. Threshold cycle Ct, which correlates inversely with the target mRNA levels, was calculated using the second derivative maximum algorithm provided by LightCycler software (Bio-Rad). For each cDNA, the LC3 mRNA levels were normalized to -actin mRNA levels. Results are expressed as the ratio of normalized LC3 mRNA levels of treated cells to that of untreated cells.
Western blot analysis
Cells were harvested and rinsed twice with ice-cold PBS. Five volumes of Western blot lysis buffer [10 mM TrisHCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 5 mM EDTA, 1 mM phenylmethylsulphonyl fluoride, 0.28 g/ml aprotinin, 50 g/ml leupeptin, 1 mM benzamidine, and 7 g/ml pepstatin A] for each volume of cell pellets was added and the mixture was sonicated on ice (1 s/ml per sonicate, waiting 30 s between intervals, carried out five times). The mixture was microcentrifuged at 10,600 g at 4 ºC for 10 min and the supernatant was preserved at 70 ºC for later use. Protein concentration was determined with a BCA kit (Pierce, Rockford, USA). Proteins were separated by 12% sodium SDS-PAGE gel, transferred to a nitrocellulose membrane, and immunoblotted with primary antibody 1:500 (Cell Signaling Technology) at 4 ºC overnight. The immunoreactivites were detected using horseradish peroxidase-conjugated anti-rabbit antibody (Sigma) used 1:5000 in blocking solution for 1 h at room temperature. Immunoreactivity was detected with an enhanced chemiluminescence kit (Amersham Pharmacia Bi otech, Piscata way, USA) a nd visuali zed by autoradiography. Protein -actin (Sigma) was used as the loading control.
Statistical analysis
All data are presented as the mean±SD. Statistical analysis was carried out by ANOVA followed by Dunnett's t-test, considering P<0.05 as significant.
Results
Cell viability was inhibited after LY29400 treatment LY294002 inhibited SGC7901 viability in a dose-dependent and time-dependent fashion. MTT assays revealed that, after 24 h of treatment, the rate of inhibition reached 20. 71%±4.13% at the highest dose of 50 M, and after 48 h of treatment the rate of inhibition was found to be approximately 41.54%±2.06%. When the incubation time was prolonged to 72 h, the inhibition rate rose to 64.09%± 1.65% (Fig. 1) . Fig. 1 Reduced viability of gastric cancer SGC7901 cells after LY294002 treatment SGC7901 cells (7 10 4 cells/ml) were cultured with various doses of LY294002 for the indicated times and cell viability was analyzed by MTT assay. Values given are the mean±SD of three independent experiments. *P<0.05 compared to control; # P<0.01 compared to control.
Apoptosis was induced in SGC7901 cells after LY294002 treatment
Treatment with 50 M LY294002 for 6, 12, or 24 h in SGC7901 cells produced intense Hoechst-positive staining of condensed nuclei, indicative of apoptosis. Significant increase in Hoechst staining was observed along with apoptosis when cells were treated with 50 M LY294002. We also used immunofluorescence staining for activated caspase-3 to detect apoptotic conditions after treatment with LY294002. The activation of caspase-3 signifies the beginning of apoptosis. All the results indicated that LY294002 induced apoptosis (Fig. 2) .
LY294002 increased autophagic vacuoles
The autofluorescent substance MDC has been shown to be a marker for late autophagic vacuoles but not endosomes [16] . The dye is trapped in acidic, membranerich organelles and also shows increased fluorescence quantum yield in response to the compacted lipid bilayers present in late autophagic vacuoles [18] . When cells are viewed with a fluorescence microscope, autophagic vacuoles stained by MDC appear as distinct dot-like structures distributed within the cytoplasm or localizing in the perinuclear regions. We found that there was an increase in the number of MDC-labeled vesicles after treatment with LY294002 from 6 to 24 h (Fig. 3) .
LY294002 increased acidic vesicular organelles
The maturation of autophagosomes to autolysosomes is accompanied by an increase in the acidity of the lumen [20] . Therefore, to assess the relative number of autolysosomes in control versus LY294002-treated cells, we used an assay that measures supravital staining of acidic compartments with the lysosomotropic agent AO. When the dye enters an acidic compartment, the protonated form becomes trapped in aggregates that fluoresce bright red or orange [20 22] . Although AO stains lysosomal a nd late endosoma l compa r tments as well a s autolysosomes, extensive studies have established that a substantial increase in AO-positive acidic vesicular organelles also occurs in conjunction with the induction of macroautophagy in glioblastoma cells [14,22 24] . As shown in Fig. 4 , a general increase in the intensity of AOpositive structures could be detected in LY294002-treated cells, but not in the control cells. The results confirmed that LY294002 treatment stimulates a large increase in the amount of AO sequestered into acidic vesicular organelles.
LY294002 up-regulated expression of LC3 mRNA
To assay if LY294002 increases the expression of autophagic genes, real-time quantitative RT-PCR analysis was used to detect the expression of LC3. The results showed that the basal level of LC3 mRNA in SGC7901 cells was low. After incubation with LY294002, the LC3 mRNA expression was significantly increased after 6 h (Fig. 5) .
LY294002 increased expression of p53 and PUMA
The tumor suppressor and nuclear transcription factor p53 is a tetramer phosphoprotein that can regulate several major cellular functions including gene transcription, DNA synthesis, DNA repair, cell cycle regulation, senescence, and cell death [25, 26] . p53 is activated by cell stress and DNA damage and, depending on the severity of the stress and the particular cell type, might aid in adaptive responses to the stress, or trigger cell cycle arrest or apoptosis [27] . When the inhibitor of class I PI3K, LY294002, was applied, the autophagic level was significantly increased and the apoptotic level was increased, indicating that class I PI3K is a key regulator of both autophagy and apoptosis. In addition, when p53 was activated by LY294002, the level of autophagy was up-regulated, indicating that p53 is relevant to autophagy and apoptosis and p53 activation increased autophagy levels, and at the same time, the apoptotic was induced (Fig. 6) .
PUMA is a downstream target of the p53 tumor suppressor gene and a member of the BH3-only group of Bcl-2 family proteins [28, 29] . The activation of PUMA by DNA damage is dependent on p53 and is mediated by the direct binding of p53 to the PUMA promoter region [30] . PUMA plays an essential role in p53-dependent and p53-independent apoptosis induced by a variety of stimuli [30] . In this study, using the inhibitor of class I PI3K, LY294002, p53 was activated and the MAP1-LC3 levels were up-regulated, with increased apoptosis and significantly increased expression of PUMA (Fig. 7) .
Discussion
Autophagy is a genetically programmed, evolutionarily conserved process that degrades long-livedcellular proteins and organelles. Autophagy is important in normal development and response to changing environmental stimuli and, in addition to its role in cancer, is important in numerous diseases, including bacterial and viral infections, neurodegenerative disorders, and cardiovascular disease [11] . Recent studies have suggested that there are three types of PCD: apoptosis (PCD I); autophagic cell death (PCD II); and necrosis (PCD III) [31] .
The relationship between autophagy and apoptosis is very complicated. Boya et al [32] hypothesized that autophagy is needed to prevent apoptosis as a cell survival mechanism. Edinger and Thompson [31] were of the opinion that autophagy activates apoptosis and necrosis as a beginning factor. Although there has been great progress in autophagy since 2003, the relationship between autophagy and apoptosis is still discussed.
LC3 is an autophagosomal ortholog of yeast Atg8. LC3 has been best characterized as an autophagosomal marker in mammalian autophagy, and the levels of LC3 might also reflect the levels of autophagy [33] . Our results showed that the basal level of LC3 mRNA in SGC7901 cells was low. After incubation with LY294002, the LC3 mRNA expression was significantly increased after 6 h.
The tumor suppressor p53 plays a central role in sensing various genotoxic stresses. Here, we showed that these two important cellular signaling pathways, p53 and class I PI3K/AKT/mTOR, communicate with each other. p53 activation by a physiologically relevant stress signal, DNA damage, inhibits mTOR activity in normal cells [34] . The inhibitor of mTOR might activate p53 and autophagy. Autophagy is a lysosome-dependent cellular degradative process that, in the extreme case, could lead to cell death (PCD II). Autophagy appears to represent a unique tumor suppression mechanism. The activation of p53 dramatically increases autophagy levels in cells, perhaps contributing to the tumor suppressor functions of p53. The results of activation of p53 might rely on the autophagy and apoptosis levels and the relationship between autophagy and apoptosis. Low levels of p53 activation and autophagy might promote cell proliferation and protect them against cell death, and when the levels of activation of p53 extend to some degrees, it could induce cell death by activating p53 and autophagy.
In this study, when using the inhibitor of class I PI3K, LY294002, the level of p53 and autophagy was activated. At the same time the expression of PUMA was up-regulated and the level of apoptosis and necrosis was increased. These results could prove the effects of class I PI3K/ AKT/mTOR and p53 in regulating autophagy, apoptosis, and necrosis. All of these observations suggest that autophagy and p53 activation might have significant contributions to LY294002-induced death of SGC7901 cells. Further investigation of upstream signal regulation of autophagy and apoptosis could provide new insights into the mechanisms accommodating or contributing to autophagy and apoptosis, thereby unveiling new strategies for tumor therapy. 
